Literature DB >> 26278055

Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.

Saverio Candido1, Stephen L Abrams2, Linda S Steelman2, Kvin Lertpiriyapong3, Timothy L Fitzgerald4, Alberto M Martelli5, Lucio Cocco5, Giuseppe Montalto6, Melchiorre Cervello7, Jerry Polesel8, Massimo Libra9, James A McCubrey10.   

Abstract

Various, diverse molecules contribute to the tumor microenvironment and influence invasion and metastasis. In this review, the roles of neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) in the tumor microenvironment and sensitivity to therapy will be discussed. The lipocalin family of proteins has many important functions. For example when NGAL forms a complex with MMP-9 it increases its stability which is important in cancer metastasis. Small hydrophobic molecules are bound by NGAL which can alter their entry into and efflux from cells. Iron transport and storage are also influenced by NGAL activity. Regulation of iron levels is important for survival in the tumor microenvironment as well as metastasis. Innate immunity is also regulated by NGAL as it can have bacteriostatic properties. NGAL and MMP-9 expression may also affect the sensitivity of cancer cells to chemotherapy as well as targeted therapy. Thus NGAL and MMP-9 play important roles in key processes involved in metastasis as well as response to therapy. This article is part of a Special Issue entitled: Tumor Microenvironment Regulation of Cancer Cell Survival, Metastasis, Inflammation, and Immune Surveillance edited by Peter Ruvolo and Gregg L. Semenza.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug resistance; Iron transport; Lcn2; Lipocalins; MMP-9; NGAL; Siderocalins

Mesh:

Substances:

Year:  2015        PMID: 26278055     DOI: 10.1016/j.bbamcr.2015.08.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis.

Authors:  Hao-Jie Yang; Zhe Guo; Yu-Ting Yang; Jing-Hang Jiang; Ya-Peng Qi; Ji-Jia Li; Le-Qun Li; Bang-De Xiang
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

Review 2.  Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types.

Authors:  Sina Rahimi; Amaneh Mohammadi Roushandeh; Ebrahim Ahmadzadeh; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Mol Biol Rep       Date:  2020-01-22       Impact factor: 2.316

3.  Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activation.

Authors:  Xiaobin Ma; Xinhua Pan; Yinglei Wei; Binhe Tan; Linli Yang; Hua Ren; Min Qian; Bing Du
Journal:  Oncotarget       Date:  2016-05-17

4.  Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.

Authors:  Kun-Chun Chiang; Ta-Sen Yeh; Ren-Chin Wu; Jong-Hwei S Pang; Chi-Tung Cheng; Shang-Yu Wang; Horng-Heng Juang; Chun-Nan Yeh
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

5.  Metformin alleviates nickel-induced autophagy and apoptosis via inhibition of hexokinase-2, activating lipocalin-2, in human bronchial epithelial cells.

Authors:  Yu-Ting Kang; Wen-Cheng Hsu; Chih-Hsien Wu; I-Lun Hsin; Pei-Ru Wu; Kun-Tu Yeh; Jiunn-Liang Ko
Journal:  Oncotarget       Date:  2017-11-06

6.  NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.

Authors:  Claudio Guarneri; Valentina Bevelacqua; Jerry Polesel; Luca Falzone; Patrizia S Cannavò; Demetrios A Spandidos; Grazia Malaponte; Massimo Libra
Journal:  Oncol Rep       Date:  2017-01-10       Impact factor: 3.906

7.  Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer.

Authors:  Luca Falzone; Saverio Candido; Rossella Salemi; Maria S Basile; Aurora Scalisi; James A McCubrey; Francesco Torino; Salvatore S Signorelli; Maurizio Montella; Massimo Libra
Journal:  Oncotarget       Date:  2016-11-08

8.  Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis.

Authors:  Jun Wu; Jing Wang; Qiang Su; Wei Ding; Teng Li; Junxian Yu; Bangwei Cao
Journal:  Onco Targets Ther       Date:  2018-05-09       Impact factor: 4.147

Review 9.  Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning.

Authors:  Sigrid A Langhans
Journal:  Front Pharmacol       Date:  2018-01-23       Impact factor: 5.810

10.  ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma in vivo.

Authors:  Yuji Wang; Xinyi Xu; Ce Song; Jianhui Wu; Xi Hu; Haimei Zhu; Xiaoyi Zhang; Yaonan Wang; Lin Gui; Ming Zhao; Shiqi Peng
Journal:  Oncotarget       Date:  2017-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.